IDEAYA Biosciences (NASDAQ:IDYA) Price Target Raised to $36.00
IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price objective boosted by Royal Bank of Canada from $32.00 to $36.00 in a report published on Tuesday morning, Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other equities analysts have also commented on the stock. SVB Leerink assumed coverage on shares […]
More Stories
Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Update
Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) was the recipient of a large drop in short interest during the...
AppTech Payments Corp. (NASDAQ:APCX) Short Interest Update
AppTech Payments Corp. (NASDAQ:APCX – Get Free Report) was the target of a large growth in short interest in December....
Deutsche Post AG (OTCMKTS:DHLGY) Sees Significant Growth in Short Interest
Deutsche Post AG (OTCMKTS:DHLGY – Get Free Report) was the target of a significant growth in short interest during the...
Hyundai Motor (OTCMKTS:HYMTF) Short Interest Update
Hyundai Motor (OTCMKTS:HYMTF – Get Free Report) was the target of a significant growth in short interest during the month...
VanEck J.P. Morgan EM Local Currency Bond ETF (NYSEARCA:EMLC) Sets New 12-Month Low – Should You Sell?
Shares of VanEck J.P. Morgan EM Local Currency Bond ETF (NYSEARCA:EMLC – Get Free Report) reached a new 52-week low...
Gevo (NASDAQ:GEVO) Shares Gap Up – Time to Buy?
Gevo, Inc. (NASDAQ:GEVO – Get Free Report) gapped up before the market opened on Friday . The stock had previously...